The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent
- PMID: 10946296
- DOI: 10.4049/jimmunol.165.5.2665
The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent
Abstract
IL-12 has been demonstrated to have potent anti-tumor activities in a variety of mouse tumor models, but the relative roles of NK, NKT, and T cells and their effector mechanisms in these responses have not been fully addressed. Using a spectrum of gene-targeted or Ab-treated mice we have shown that for any particular tumor model the effector mechanisms downstream of IL-12 often mimic the natural immune response to that tumor. For example, metastasis of the MHC class I-deficient lymphoma, EL4-S3, was strictly controlled by NK cells using perforin either naturally or following therapy with high-dose IL-12. Intriguingly, in B16F10 and RM-1 tumor models both NK and NKT cells contribute to natural protection from tumor metastasis. In these models, a lower dose of IL-12 or delayed administration of IL-12 dictated a greater relative role of NKT cells in immune protection from tumor metastasis. Overall, both NK and NKT cells can contribute to natural and IL-12-induced immunity against tumors, and the relative role of each population is tumor and therapy dependent.
Similar articles
-
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.Cancer Immunol Immunother. 2007 Aug;56(8):1153-61. doi: 10.1007/s00262-006-0264-1. Epub 2006 Dec 8. Cancer Immunol Immunother. 2007. PMID: 17160409 Free PMC article.
-
The contribution of NKT cells, NK cells, and other gamma-chain-dependent non-T non-B cells to IL-12-mediated rejection of tumors.J Immunol. 2003 Feb 1;170(3):1197-201. doi: 10.4049/jimmunol.170.3.1197. J Immunol. 2003. PMID: 12538676
-
Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.J Immunol. 2001 Jul 1;167(1):424-34. doi: 10.4049/jimmunol.167.1.424. J Immunol. 2001. PMID: 11418679
-
Regulation and antimetastatic functions of liver-associated natural killer cells.Immunol Rev. 2000 Apr;174:63-76. doi: 10.1034/j.1600-0528.2002.00014h.x. Immunol Rev. 2000. PMID: 10807507 Review.
-
Antitumor activities of IL-12 and mechanisms of action.Chem Immunol. 1997;68:153-74. doi: 10.1159/000058690. Chem Immunol. 1997. PMID: 9329221 Review. No abstract available.
Cited by
-
CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.Cancer Immunol Immunother. 2007 Apr;56(4):563-72. doi: 10.1007/s00262-006-0215-x. Epub 2006 Aug 22. Cancer Immunol Immunother. 2007. PMID: 16924493 Free PMC article.
-
Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.J Exp Med. 2005 Dec 19;202(12):1679-89. doi: 10.1084/jem.20051473. Epub 2005 Dec 13. J Exp Med. 2005. PMID: 16352740 Free PMC article.
-
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.Front Immunol. 2020 Apr 22;11:702. doi: 10.3389/fimmu.2020.00702. eCollection 2020. Front Immunol. 2020. PMID: 32391013 Free PMC article. Review.
-
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice.J Transl Med. 2008 May 19;6:26. doi: 10.1186/1479-5876-6-26. J Transl Med. 2008. PMID: 18489769 Free PMC article.
-
Cytokine-Induced Modulation of Colorectal Cancer.Front Oncol. 2016 Apr 19;6:96. doi: 10.3389/fonc.2016.00096. eCollection 2016. Front Oncol. 2016. PMID: 27148488 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
